Digital Polymerase Chain Reaction (PCR) Technology: Global Markets
LONDON, Oct. 14, 2014 /PRNewswire/ -- This BCC Research report analyzes the Polymerase Chain Reaction (PCR) industry, its trend forecasts and sales through 2018. It also identifies the market opportunities focusing on the position of PCR in the larger marketplace, its applications, and its implications on complementary applications, especially next generation sequencing. Key manufacturers, suppliers users and variety of factors influencing the technology are also mentioned in this report.
Use this report to:
- To focus on the equipment used within the digital PCR sector and the particular reagents used therein that are specifically dedicated within.
- To identify the plethora of market opportunities using digital PCR.
- Receive information on governmental regulations.
- Receive information on industry structure and a competitive analysis.
Highlights
- The global market for digital polymerase chain reaction (PCR) technology reached $81.8 million in 2012 and $139.3 million in 2013. The market is expected to grow to $489.8 million in 2018, a compound annual growth rate (CAGR) of 28.6% for the five-year period, 2013 to 2018.
- The equipments segment of the market reached $68.2 million in 2013 and is expected to grow to $283.9 million in 2018, a CAGR of 33%.
l The consumables market reached $71.1 million in 2013 and is expected to grow to $205.9 million in 2018, a CAGR of 23.7%.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This report will provide BCC Research's analysis on the digital polymerase chain reaction (PCR) industry, including trend forecasts and sales through 2018. The key
manufacturers, suppliers, users and variety of factors influencing demand are discussed. This report will identify the plethora of market opportunities using digital
PCR, focusing on where it can establish itself in the broader PCR marketplace, the applications of the technology, and the implications this technology will have on
complementary applications, in particular with next-generation sequencing as it enters the broader marketplace. Digital PCR has only been widely marketed in the past couple of years, but it will likely be on a similar growth path as real-time PCR technology 10 years ago.
REASONS FOR DOING THE STUDY
Digital PCR is a novel application of the now 30-year-old PCR technology. While there are a number of different technologies in the marketplace, the concept involves
partitioning a sample of DNA into small, microscopic droplets so that a given sample has either 0 or 1 copy of target DNA, much in the way a microchip has switches that
gives signals of 0 or 1 within a microchip. Once the sample is partitioned, a PCR reaction takes place in each droplet, which is then detected by technologies similar to
those used within quantitative PCR today. These results are interpreted with the use of Poisson statistics to determine the exact copy number of target DNA within a sample.
This methodology has the ability to quantify small copy numbers of DNA within a sample, and can have a wide variety of applications complementary to existing PCR
technology, as well as new uses of PCR that would not be feasible with other technologies — particularly as a complement to next-generation sequencing. There are
three different variations of digital PCR being marketed, and they all have their strengths and weaknesses in the marketplace.
SCOPE OF REPORT
The report will discuss in detail the marketplace for digital PCR. The focus of this report is on the equipment used within the digital PCR sector and the particular reagents used therein that are specifically dedicated within. The different technologies used for digital PCR and their associated reagents were analyzed to explore the scope of the
marketplace that exists for this technology.
INTENDED AUDIENCE
The intended audience for this report is key thought leaders in the pharmaceutical, biotechnology and clinical diagnostics industries, executives within the pharmaceutical,
biotechnology and clinical diagnostics industries and the firms that market supplies and equipment to these firms, business development professionals within the
biotechnology industry, scientific and quality control staff.
INFORMATION SOURCES
The information for this BCC report was obtained through primary and secondary sources of data. Primary data sources include interviews with a number of executives,
product managers and laboratory professionals across a number of different segments in the market. Secondary data sources include published literature in the field of digital
PCR, investment reports, company reports and media information for the laboratory industry.
The market data presented is based on the manufacturers' level. The base year of the market report is 2013, with historical data from 2011 and 2012, and forecasts to 2018.
Historical and forecast data are provided for all market segments referred to in this report. Competitor share estimates are provided based on data from the 2013 base
year.
While this report will discuss complementary technologies as applicable, it will not highlight their market specifics. Of particular note are the vast majority of reagents
used for PCR, as there is significant overlap between those used between digital PCR and real-time PCR. This report will focus on the equipment used for digital PCR,
reagents specific to the technology and any particular applications. There will be significant coverage of the end users of this equipment, from academic to industry to
clinical laboratories and others.
Download the full report: https://www.reportbuyer.com/product/2171940/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article